Relationship between Urinary Norepinephrine, Fibrosis, and Arrhythmias in Chronic Chagas Heart Disease with Preserved

Eduardo Marinho Tassi1, Emília Matos do Nascimento1, Marcelo Abramoff Continentino1

  • 1Instituto do Coração Edson Saad, Faculdade de Medicina, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ - Brasil, Rio de Janeiro, RJ - Brasil.

Insights

In Chronic Chagas Cardiomyopathy (CCC), autonomic nervous system integrity is linked to lower fibrosis and higher ejection fraction, despite traditional risks. Norepinephrine levels correlate with ejection fraction and fibrosis, but not ventricular arrhythmias.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Imaging

Background:

  • Chronic Chagas Cardiomyopathy (CCC) requires identification of arrhythmogenic risk factors, especially in patients without moderate to severe ventricular dysfunction.
  • Understanding these factors is crucial for managing sudden cardiac death risk in early-stage CCC.

Purpose of the Study:

  • To investigate the correlation between frequent premature ventricular contractions (PVCs), left ventricular ejection fraction (LVEF), myocardial fibrosis extent (via Cardiac Magnetic Resonance - CMR), and urinary norepinephrine (NOREPI) in CCC patients with preserved or mildly reduced LVEF.
  • To assess the predictive ability of these variables in early-stage CCC.

Main Methods:

  • Prospective study including 59 CCC patients.
  • Holter monitoring for PVCs (>30/h), CMR for LVEF and fibrosis quantification, and urinary NOREPI measurement (Muskiet method).
  • Correlation coefficient matrix analysis was used to determine relationships between variables (p < 0.05 significance).

Main Results:

  • Fibrosis was inversely proportional to LVEF (R=-0.61) and NOREPI (R=-0.68).
  • PVCs were inversely proportional to LVEF (R=-0.33) and NOREPI (R=-0.27).
  • LVEF showed a direct positive correlation with NOREPI (R=0.83).

Conclusions:

  • In CCC patients with preserved/mildly reduced LVEF, autonomic nervous system integrity correlates with less myocardial fibrosis and higher LVEF.
  • A significant correlation exists between NOREPI levels, LVEF, and myocardial fibrosis.
  • However, PVCs were not found to be correlated with these parameters in this specific patient subgroup.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
501
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
50
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
476